Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders
Abstract. Incomplete immune reconstitution remains a global challenge for human immunodeficiency virus (HIV) treatment in the present era of potent antiretroviral therapy (ART), especially for those individuals referred to as immunological non-responders (INRs), who exhibit dramatically low CD4+ T-c...
Main Authors: | Silvere D. Zaongo, Yaokai Chen, Yanjie Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-09-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002493 |
Similar Items
-
PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review
by: Silvere D. Zaongo, et al.
Published: (2023-10-01) -
Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review
by: Silvere D. Zaongo, et al.
Published: (2021-11-01) -
The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives
by: Farooq Rashid, et al.
Published: (2023-01-01) -
An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
by: Silvere D. Zaongo, et al.
Published: (2023-06-01) -
The role of pyroptosis in incomplete immune reconstitution among people living with HIV:Potential therapeutic targets
by: Chao Xia, et al.
Published: (2023-11-01)